Cancer trials aimed at 'surrogate' targets miss bigger mark — study
Find a random person on the street and ask them what a cancer drug should do. What are the odds they don’t say “it should …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
